Library
25iP-NBOMe
25iP-NBOMe is a synthetic psychedelic of the substituted phenethylamine class, specifically an N-benzylated derivative of the hallucinogen 2C-iP. It has emerged as a rarely encountered novel designer drug and remains largely unresearched. Reported to be extremely potent with stimulating qualities, it may produce uncomfortable body load and potentially dangerous vasoconstriction at higher doses. Very limited information is available regarding its safety profile and pharmacological properties.
Also known as: 25ip, 2c-ip-nbome, Nbome-2c-ip, 25iP-NBMe
Classification
- Chemical: Phenethylamine
- Psychoactive: Psychedelic
- Tag: Hallucinogen
- Tag: NBOMe
- Tag: Research-Chemical
- Tag: Tentative
Effects
- Stimulation
- Restlessness
- Pupil Dilation
- Muscle Tension
- Temperature Regulation Suppression
- Mentalphysical Stimulation
- Introspection
- Confusion
- Euphoria
- Empathy Enhancement
- Ego Dissolution
- Wakefulness
- Appetite Suppression
- Tactile Enhancement
- Color Enhancement
- Brightened Color
- Closedopen Eye Visuals
- Enhanced Tactile Sensation
Routes of Administration
Sublingual
Dosage
- Heavy: 1.5 mg
- Light: 300 – 750 µg
- Common: 750 – 1000 µg
- Strong: 1000 – 1500 µg
- Threshold: 250 ug
Duration
- Onset: 0.5-1 h
- After Effects: 1-12 h
Buccal
Dosage
- Heavy: 1500 µg + (↑ risk)
- Light: 250–600 µg
- Common: 600–1000 µg
- Strong: 1000–1500 µg
- Threshold: 150–250 µg
Duration
- Onset: 0.33-0.75 h
- Peak: 2-4 h
- Offset: 4-7 h
- After Effects: 7-18 h
- Total Duration: 5-10 h
Insufflated
Dosage
- Heavy: 900 µg + (↑ risk)
- Light: 150–350 µg
- Common: 350–600 µg
- Strong: 600–900 µg
- Threshold: 75–150 µg
Duration
- Onset: 0.08-0.25 h
- Peak: 1-3 h
- Offset: 3-6 h
- After Effects: 6-16 h
- Total Duration: 4-8 h
Oral
Dosage
- Heavy: 2500 µg + (unpredictable)
- Light: 700–1200 µg
- Common: 1200–1800 µg
- Strong: 1800–2500 µg
- Threshold: 500–700 µg
Duration
No data available for this section yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
